Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 1 |
2013 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopause.
Menopause. 2013 Jan;20(1):47-56. doi: 10.1097/gme.0b013e3182775fe9.
Menopause. 2013.
PMID: 23266840
Clinical Trial.
Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.
Pinkerton JV, Constantine G, Hwang E, Cheng RF; Study 3353 Investigators.
Pinkerton JV, et al.
Menopause. 2013 Jan;20(1):28-37. doi: 10.1097/gme.0b013e31826421a8.
Menopause. 2013.
PMID: 23010882
Clinical Trial.
Item in Clipboard
Efficacy and tolerability of a "suprabioavailable" formulation of fenofibrate in patients with dyslipidemia: a pooled analysis of two open-label trials.
Ramjattan BR, Callaghan DJ, Theiss U.
Ramjattan BR, et al.
Clin Ther. 2002 Jul;24(7):1105-16. doi: 10.1016/s0149-2918(02)80022-4.
Clin Ther. 2002.
PMID: 12182255
Item in Clipboard
Cite
Cite